Aura Biosciences, Inc. 10-K filing
Filed 2026-03-30 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-130401
- Form type
- 10-K
- CIK
- 0001501796
- Primary document
- https://www.sec.gov/Archives/edgar/data/1501796/000119312526130401/aura-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aura Biosciences, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-112.8M | - | - |
| Net Income | $-106.2M | - | - |
| Eps Basic | -1.76 | - | - |
| Eps Diluted | -1.76 | - | - |
| Cash And Equivalents | $59.5M | - | - |
| Total Assets | $169.4M | - | - |
| Total Liabilities | $32.5M | - | - |
| Shareholders Equity | $136.9M | - | - |
| Operating Cash Flow | $-84.7M | - | - |
| Capital Expenditures | $447,000 | - | - |